Economic Burden for Lung Cancer Survivors in Urban China-Reference-Cited by-同舟云学术

Economic Burden for Lung Cancer Survivors in Urban China

Published:2017-03-15 Issue:3 Volume:14 Page:308
ISSN:1660-4601
Container-title:International Journal of Environmental Research and Public Health
language:en
Short-container-title:IJERPH

Author:

Zhang Xin,Liu Shuai,Liu Yang,Du Jian,Fu Wenqi,Zhao Xiaowen,Huang Weidong,Zhao Xianming,Liu Guoxiang,Mao Zhengzhong,Hu Teh-wei

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

Link

http://www.mdpi.com/1660-4601/14/3/308/pdf

Reference41 articles.

1. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx?cancer=lung

2. Epidemiology of lung cancer in China

3. The treatment of lung cancer;Bai;Zhonghua Jie He He Hu Xi Za Zhi,2006

4. Economic and social changes among distressed family caregivers of lung cancer patients

5. The direct economic cost of lung cancer;Xu;Chin. Health Econ.,2005

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The usage and costs of national drug price-negotiated anticancer medicines in a first-tier city in Northeast China: a study based on health insurance data;BMC Public Health;2024-05-14

2. Cost-effectiveness of additional serplulimab to chemotherapy in metastatic squamous non-small cell lung cancer patients;Frontiers in Immunology;2024-04-22

3. A circRNA-based ceRNA network shows its diagnostic value in non-small-cell lung cancer;Clinical Biochemistry;2023-11

4. Economic burden of advanced lung cancer patients treated by gefitinib alone and combined with chemotherapy in two regions of China;Journal of Medical Economics;2023-10-31

5. How National Health Insurance Coverage Policy Affected the Use of Trastuzumab and Rituximab in China: A Bicentric Retrospective Study;Risk Management and Healthcare Policy;2023-09